Clinical Trials Browser

Phase 2 × temsirolimus × Tumor-Agnostic × Clear all

NCT02142036 2019-03-13

MetAction

Phase 2 Completed

Neoplasm Metastasis

NCT01009203 2015-08-10

Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma

Phase 2 Terminated

13 enrolled 8 charts

Carcinoma, Squamous Cell